The CAMBRIA-2 Clinical Trial - Wendy Rolls

Dr. Chan on ExteNET Trial for HER2+ Breast CancerПодробнее

CodeBreaK100: detecting mechanisms of intrinsic resistance by ctDNAПодробнее

Case 1: Adjuvant Therapy for Residual Disease in HER2+ Breast CancerПодробнее

The CAMBRIA-2 Clinical TrialПодробнее

Wendy's StoryПодробнее

The CAMBRIA-2 Clinical Trial AnimationПодробнее

Considerations for molecular testing for HER2+ gastric cancerПодробнее

Wendy’s Breast Cancer Clinical TrialПодробнее

Rationale for targeting FPR2 in female patients with pancreatic cancerПодробнее

Key clinical trials investigating immunotherapy in HER2+ and HR+ breast cancerПодробнее

CORALLEEN: kicking chemo?Подробнее

Assessing the utility of CTC count-driven therapy in breast cancerПодробнее

Changing Policies Through ResearchПодробнее

Phases of Clinical TrialsПодробнее

CAMBRIA-1: camizestrant vs standard endocrine therapy in breast cancerПодробнее

FAST-Forward trialПодробнее

CAMBRIA 1: camizestrant ER+/HER2- early breast cancerПодробнее